TCDB is operated by the Saier Lab Bioinformatics Group

1.A.147.  The CRISPR Effector, an Ion Channel Protein, Cam1 (Cam1) Family 

The CRISPR effector Cam1 mediates membrane depolarization for phage defence (Baca et al. 2024).  Prokaryotic type III CRISPR-Cas systems provide immunity against viruses and plasmids using CRISPR-associated Rossman fold (CARF) protein effectors. Recognition of transcripts of these invaders with sequences that are complementary to CRISPR RNA guides leads to the production of cyclic oligoadenylate second messengers, which bind CARF domains and trigger the activity of an effector domain. Whereas most effectors degrade host and invader nucleic acids, some are predicted to contain TMSs without an enzymatic function. Whether and how these CARF-TMS fusion proteins facilitate the type III CRISPR-Cas immune response was studied by Baca et al, 2024.  They investigated the role of cyclic oligoadenylate-activated membrane protein 1 (Cam1) during type III CRISPR immunity. Structural and biochemical analyses revealed that the CARF domains of a Cam1 dimer bind cyclic tetra-adenylate second messengers. In vivo, Cam1 localizes to the membrane, is predicted to form a tetrameric transmembrane pore, and provides defence against viral infection through the induction of membrane depolarization and growth arrest. These results reveal that CRISPR immunity does not always operate through the degradation of nucleic acids, but is instead mediated via a wider range of cellular responses (Baca et al. 2024).

References associated with 1.A.147 family:

Baca, C.F., Y. Yu, J.T. Rostøl, P. Majumder, D.J. Patel, and L.A. Marraffini. (2024). The CRISPR effector Cam1 mediates membrane depolarization for phage defence. Nature 625: 797-804. 38200316